BIORESTORATIVE THERAPIES INC (BRTX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$0.15+2.99%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · BRTX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 0.4 | 0.4 | 0.4 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.6 | 0.4 | 0.0 | 0.0 | — |
| Total Revenues | — | 0.3 | 0.6 | 0.6 | — | — | — | — | — | 0.1 | 0.0 | 0.6 | 0.4 | 0.0 | 0.0 | — |
| Cost of Revenues | 0.0 | 0.0 | 0.0 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Gross Profit | — | 0.3 | 0.4 | — | — | — | — | — | — | 0.1 | 0.0 | 0.4 | 0.2 | 0.0 | 0.0 | — |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 9.4 | 10.1 | 5.3 | 4.0 | 3.5 | 0.7 | 0.9 | 1.7 | 1.5 | 2.2 | 2.9 | 2.1 | 1.4 | 1.6 | 0.8 | 0.0 |
| Operating Income | (14.2) | (15.6) | (11.6) | (15.2) | (19.0) | (26.3) | (2.8) | (8.4) | (7.6) | (8.4) | (7.8) | (7.2) | (4.9) | (4.8) | (5.6) | (3.6) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | — | — | 0.3 | 0.3 | 0.4 | 0.6 | 0.3 |
| Other Non-Operating Income / Expenses | 3.2 | 1.4 | 2.6 | 4.8 | 5.8 | (18.0) | (8.5) | (6.2) | (4.9) | (1.1) | (0.9) | (0.8) | (0.7) | (1.0) | (1.0) | (0.5) |
| EBT, Incl. Unusual Items | — | (14.2) | — | — | — | — | — | — | — | (9.4) | (8.6) | (7.9) | (5.6) | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | — | — | — |
| Net Income | ||||||||||||||||
| Net Income | (11.1) | (14.2) | (9.0) | (10.4) | (13.2) | (44.3) | (11.3) | (14.6) | (12.5) | (9.4) | (8.6) | (7.9) | (5.6) | (5.8) | (6.5) | (4.1) |
| Per Share | ||||||||||||||||
| Basic EPS | (0.62) | (1.58) | (1.16) | (2.47) | (3.65) | — | — | — | — | — | — | — | — | — | — | — |
| Diluted EPS | (0.62) | (1.58) | (1.16) | (2.47) | — | — | — | — | — | — | — | — | — | — | — | — |
| Revenue per Share | 0.02 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 17.7 | 9.0 | 7.8 | 4.2 | 3.6 | — | — | — | — | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 17.7 | 9.0 | 7.8 | 4.2 | — | — | — | — | — | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | (15.4) | (11.4) | (15.1) | (18.9) | (26.2) | (2.6) | (8.2) | (7.4) | (8.1) | (7.5) | (7.0) | (4.8) | (4.6) | (5.5) | (3.5) |
| EBIT | (14.2) | (15.6) | (11.6) | (15.2) | (19.0) | (26.3) | (2.8) | (8.4) | (7.6) | (8.4) | (7.8) | (7.2) | (4.9) | (4.8) | (5.6) | (3.6) |
| Effective Tax Rate | — | — | — | — | — | — | — | — | — | — | — | 0.0% | 0.0% | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.